Exhibit 99.2
BEYONDSPRING INC.
(THE “COMPANY”)
NOTICE OF EXTRAORDINARY GENERAL MEETING OF THE
SHAREHOLDERS OF THE COMPANY
IMPORTANT
Terms not otherwise defined in this notice shall have the meanings given to such terms in the Amended and Restated Memorandum and Articles of Association of the Company adopted on 24 February 2017 and effective immediately prior to the completion of the Company’s initial public offering of ordinary shares (the “Memorandum and Articles”).
NOTICE is hereby given that an Extraordinary General Meeting of the Shareholders of the Company will be held on March 15, 2021 at 9 a.m., Eastern Standard Time, at 28 Liberty Street, 39th Floor, New York, NY 10005, for the purpose of considering and, if thought fit, passing the following ordinary resolution. In light of COVID-19 concerns, the Extraordinary General Meeting will also allow participation virtually according to the details below. All references to “in person” shall include virtual presence using one of the options provided.
Approval of the 2017 Omnibus Incentive Plan as amended and restated
1. | By way of an ordinary resolution THAT the BeyondSpring Inc. 2017 Omnibus Incentive Plan as amended and restated as of September 18, 2020, a copy of which is set out in Exhibit A annexed hereto, be and is hereby adopted and approved. |
Other Matters to be Noted
A shareholder entitled to attend and vote at the meeting is entitled to appoint a proxy to attend and vote in his/her place. A proxy need not be a shareholder of the Company. A form of proxy is attached.
To be valid, any proxy must be duly completed, signed and lodged, together with the power of attorney or other authority under which it is signed (if any) or a notarially certified copy thereof, with Continental Stock Transfer & Trust Company, 1 State Street 30th Floor, New York, New York 10004-1561, with a copy to Jason.Pesile@beyondspringpharma.com no later than the time for holding the meeting or, if the meeting is adjourned, the time for holding such adjourned meeting.
A shareholder holding more than one share entitled to attend and vote at the meeting need not cast the votes in respect of such shares in the same way on any resolution and therefore may vote a share or some or all such shares either for or against a resolution and/or abstain from voting a share or some or all of the shares and, subject to the terms of the instrument appointing any proxy, a proxy appointed under one or more instruments may vote a share or some or all of the shares in respect of which he is appointed either for or against a resolution and/or abstain from voting. Due to sanitary measures and to protect our health and our community, we encourage you using other methods of attendance than in person, such as attending virtually or telephonically or by proxy.
The quorum for the meeting is one or more shareholders holding not less than an aggregate of a majority of all voting share capital of the Company in issue present in person or by proxy.
Please consult the Proxy Statement enclosed herewith and available on the Company’s website as to the procedures for attending the Extraordinary General Meeting or to be represented by way of proxy.